AbSci

AbSci is a leading synthetic biology company that reshapes the biopharmaceutical drug discovery process by translating ideas into drugs through its integrated Drug Creation (TM) platform technology. We have customized our patented SoluPro E. coli expression system to discover novel next-generation protein biologics in full-length format while developing optimized production cell lines. Cutting-edge deep learning AI is being deployed to inform our designs, successfully achieving what others consider impossible on a daily basis.